biotech.today

Details

  • ●Modalities: small molecules
  • ●Therapeutic areas: cardiovascular, oncology, neurodegeneration
  • ●Key targets:
  • ●Indications: chronic kidney disease, hypertension
  • ●Funding: Undisclosed

Partners & investors

  • Novartis· Investor
  • Third Rock· Investor

Key considerations

  • ●AI tools in use: Opal Platform
  • ●Novartis partnership 2023
  • ●Flagship + Third Rock led funding

Pipeline

  • Phase 21
Get live updates on Valo Health’s hiring, filings, and partnerships. Follow in BT Pro →
Source: Company website, SEC / Companies House filings, press releases, Crunchbase · biotech.today analysis (Apr 2026)

Key people

David Berry

Co-Founder & CEO

biotech-entrepreneurship
Visit website →LinkedIn →